| aPDT | Antimicrobial photodynamic therapy |
| BOP | Bleeding on probing |
| BTF | Bio-enhanced turmeric formulation |
| CAL | Clinical attachment level |
| CMS | Carboxymethyl starch |
| COX-2 | Cyclooxygenase-2 |
| CS | Chitosan |
| CRP | C-reactive protein |
| DNA | Deoxyribonucleic acid |
| EGF | Epidermal growth factor |
| EMT | Epithelial–mesenchymal transition |
| GI | Gingival index |
| HNC | Head and neck cancer |
| IL-1β | Interleukin 1β |
| IL-6 | Interleukin-6 |
| IL-8 | Interleukin-8 |
| LDD | Local drug delivery |
| MA | Mefenamic acid |
| MDA | Malondialdehyde |
| MDSC | Myeloid-derived suppressor cells |
| MF | Mucosal flexibility |
| MIT | Modified intention to treat |
| MMT | Montmorillonite |
| MO | Mouth opening |
| MOMI | Modified oral mucositis index |
| NF- κB | Nuclear factor kappa B |
| NRS | Numerical rating scale |
| OLP | Oral lichen planus |
| OPMDs | Oral potentially malignant disorders |
| OSCC | Oral squamous carcinoma |
| OSMF | Oral submucosal fibrosis |
| PBM | Photobiomodulation |
| PCT | Procalcitonin |
| PI | Plaque index |
| PLA | Poly lactide |
| PLGA | Poly lactide-co-glicolide |
| PP | Per protocol |
| PPD | Periodontal probing depth |
| RANK | Receptor activator of nuclear factor κB |
| RANKL | Receptor activator of nuclear factor κΒ ligand |
| RAS | Recurrent aphthous stomatitis |
| RIOM | Radiation-induced oral mucositis |
| ROS | Reactive oxygen species |
| PLGA | Poly lactide-co-glicolide |
| SRP | Scaling and root planing |
| SPT | Surgical periodontal therapy |
| TGF-β | Transforming growth factor β |
| TP | Tongue protrusion |
| VAS | Visual analog scale |
| 8-OHdG | 8-hydroxydeoxyguanosine |